Logo Drug Research


Here you can find the latest news about the activities of the Helmholtz Drug Research.


A novel drug treatment strategy to fighting resistant cancer

Scientists from FMP, MDC and Charité have discovered new selective and potent active site SHP2 inhibitors, which are able to suppress cancer related metastasis and resistance formation in advanced cellular models.

The results, published in the Journal of Medicinal Chemistry, provide a potential new axis for the treatment of drug-resistant cancers with diminished ERK-signaling.

Original Publication: https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01265

back to Overview

Do you have questions?